Medical research

Inactive pill ingredients could raise the dose of your medication

The average medication contains a mix of eight "inactive" ingredients added to pills to make them taste better, last longer, and stabilize the active ingredients within. Some of those additives are now getting a closer look ...

Oncology & Cancer

Researchers uncover key to greater efficacy in cancer treatment

Researchers from Mount Sinai and IBM have discovered a novel clue in explaining how cancer cells with identical genomes can respond differently to the same therapy. In a Nature Communications paper published today, researchers ...

Medical research

Stressing cancer with spice

A new study by scientists in Japan and Indonesia reports how an experimental drug agent stops cancer cells from growing. A little over a decade ago, Indonesian scientists first reported pentagamavumon-1 (PGV-1), an analogue ...

Oncology & Cancer

Could a NOSH-aspirin-a-day keep cancer away?

The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be, not only an extremely potent cancer-fighter, but even safer than ...

Oncology & Cancer

Machine learning that predicts anti-cancer drug efficacy

With the advent of pharmacogenomics, machine learning research is well underway to predict patients' drug response that varies by individual from the algorithms derived from previously collected data on drug responses. Entering ...

page 3 from 19